Novartis

Geneva -- Swiss pharmaceutical giant Novartis International said Monday it would exercise an option to buy 52 percent of eye care company Alcon for $28.1 billion.

Novartis (NYSE: NVS) has lots of moving parts, making it tricky to analyze, but it looks to me like the overall picture is pretty healthy.